Clinical Trial Solutions vs. Access Solutions. Different challenges. Different stages of the product lifecycle. The same goal: removing the complexity between a medicine and the people who need it. From trial to treatment and everywhere in between, Tanner transforms complex clinical trial and access needs into compliant, scalable programs by combining global regulatory expertise, GxP-compliant supply chain and logistics, and human-centric partnership. For 25+ years, we’ve built the expertise, infrastructure and global pathways to make that happen across 155+ countries. Today, we do it through two core solution pillars: Clinical Trial Solutions — helping pharmaceutical and biotech partners keep global studies moving with comparator sourcing and procurement, secondary packaging and labeling, and clinical supply chain and logistics. Access Solutions — creating compliant pathways to medicines worldwide through expanded and compassionate access, named patient and protocol-based programs, post-trial supply, commercial distribution, and solutions for shortages and other complex access needs. 📍 US | UK | Switzerland | Ireland
Looking for a particular Tanner Pharma Group employee's phone or email?
The Tanner Pharma Group annual revenue was $22.5 million in 2026.
Steve Scalia is the President of Tanner Pharma Group.
94 people are employed at Tanner Pharma Group.
Tanner Pharma Group is based in Charlotte, North Carolina.
The NAICS codes for Tanner Pharma Group are [32, 325, 32541, 3254].
The SIC codes for Tanner Pharma Group are [283, 28, 2834].